Age: 18 – 40
Date: 01 November – 01 March 2016
Payment on Completion: Up to £2200
Overnight Stays: 2 periods of stay
Return Visits: Up to 15
BioKinetic are currently recruiting healthy female volunteers aged 18 to 40 years to take part in a research study. The study will involve two periods of stay in the clinic and outpatient visits to the clinic.
Who is suitable for the study?
Aged 18 to 40
Body Mass Index (BMI) between 18.5 -29.9kg/m2.(We can check this for you).
Non-smokers or light smokers (average of <5 cigarettes per day). If you have stopped smoking or become a light smoker >6 months prior to trial start you may be included provided you have not been a heavy smoker (i.e. >10 pack years).
You must have a negative alcohol breath test at screening.
What will happen if I take part in this study?
Attending an initial medical screening.
Undergo assessments during one menstrual cycle without an intravaginal ring being inserted (run-in period, menstrual cycle 1 to 2).
Undergo assessments during menstrual cycles with an intravaginal ring being inserted (treatment period, menstrual cycles 2 to 3 and 3 to 4).
Attending a follow-up visit after your last menstrual cycle for thorough medical assessments.
Your total time taking part in the study will include a 42 day screening period and 4 menstrual cycles
How much payment will I receive?
Up to £2200 (This is to cover your time and any out of pocket expenses. You should note that any travel expenses incurred will be met by yourself and you will not be paid for attending the medical. The amount shown is for completion of the study). Payment will be forwarded to you at the end of the study, when all post-study medical results have been signed off by the study doctor
What is being tested?
Quinagolide, the drug being used in this study, is a medication already available in the UK in tablet form and is used for the treatment of a hormone disorder (hyperprolactinaemia). The medication is also available in other European countries and some countries outside of Europe.
This study is being conducted to investigate if a new intravaginal ring version of quinagolide can be used to treat the condition endometriosis. Endometriosis can produce pain in the pelvis and can lead to reduced fertility. It is hoped the new intravaginal ring can help this condition and allow lower doses to be administered for the condition.
What else should I know?
To make sure that you are suitable for this study you will have to undergo a thorough medical, details of which will be discussed with you prior to attending the medical. If you pass the medical you may be invited to participate in the study.
If you would like to hear more details about the study, and to book a medical, please call our recruitment team on 028 90 81 83 85 and quote ref 11115
Medicals to determine eligibility for this study will take place on the following dates:
Wednesday 4th November and Friday 13th November 2015.